SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Daddy Darth Vader

Daddy Darth Vader is trending as investors rally around the token ahead of Star Wars Day on May the Fourth, with the community actively debating whether it serves as a legitimate proxy or a volatile alternative to other meme coin projects. The conversation is dominated by calls to "erase a zero" and internal community efforts to establish the token as a community-driven project following the departure of its initial developer.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is currently drawing attention as community members debate its potential for a long-awaited breakout, driven by the ongoing launch of the LitVM testnet and growing institutional interest in associated ETPs. Despite excitement over these developments, sentiment remains polarized between long-term holders pointing to network reliability and adoption and skeptics who express frustration over the asset's stagnant performance relative to the broader crypto market.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

CockCardano ($COCK) is trending as the community highlights the project's integration of real-world assets, particularly its connection to the 'Cocky Wings' food business. Investors are actively discussing the project's revenue-sharing mechanics and passive income opportunities, maintaining high engagement through social raids and frequent mentions of its Cardano-based ecosystem.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is generating significant community buzz as a targeted vehicle for the ongoing AI memory supercycle, with investors highlighting its direct exposure to major HBM and NAND producers like SK Hynix, Micron, and Samsung. Traders are actively debating whether the funds concentration in essential AI infrastructure provides a unique growth opportunity or if the current sector-wide bullishness signals an overheated market nearing a peak.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy participants are actively debating the legitimacy of the MULN crypto token, with many community members drawing parallels to past financial controversies involving the same leadership and the failed EV venture. Skepticism is rampant as investors remain divided between those calling for a rebound and those labeling the token a recurring pump-and-dump scheme.

Veil Cash is a privacy application leveraging zk-SNARKs on Base L2, enabling verified depositors to achieve privacy and anonymity within a pool of trusted users.  Veil Cash is a non-custodial privacy protocol on Base L2. Veil Cash's goal will be enabling verified users to achieve privacy and anonymity from trusted pools.  Veil is a set of smart contracts that will allow users that are deemed as verified users to deposit into the protocol. Users can later withdraw their deposits from another address without creating a link between these two addresses.   Verified users are those who meet certain criteria based on both on-chain and off-chain data.

Veil-project

The Veil project is gaining momentum as community members highlight a renewed focus on privacy-focused cryptocurrencies, with many noting its deployment on the Base network and support from Coinbase Ventures. Supporters are actively discussing its potential as a privacy play, pointing to its low market capitalization and the broader interest in privacy-centric digital assets.

Flare is a blockchain for building applications that are interoperable with other blockchains and the internet.  ## What is Flare (FLR)?  Flare is an EVM-based Layer 1 blockchain designed to allow developers to build applications that are interoperable with blockchains and the internet. By providing decentralized access to high-integrity data, Flare enables new use cases and monetisation models.   ## What makes Flare unique?  Flare's native interoperability protocols, the State Connector and the FTSO are secured by the network itself, allowing it to reliably deliver data from a wide variety of off-chain sources in a decentralized way.   The Flare Time Series Oracle delivers highly-decentralized price and data feeds to dapps on Flare, without relying on centralized providers.   The State Connector protocols enable information, both from other blockchains and the internet to be used securely, scalably and trustlessly with smart contracts on Flare.  Risk is minimized by building this decentralized data infrastructure natively into the blockchain, powered by a large number of independent data providers.  By incentivizing sets of independent providers to query, acquire, and process data without relying on single, centralized sources, Flare’s core protocols can facilitate the development of interoperable dapps with a broad range of potential innovative use cases.   ## What is the Flare (FLR) token used for?  FLR is the native token used for payments, transaction fees to prevent spam attacks and staking in validator nodes. FLR can also be wrapped into an ERC-20 variant, WFLR. WFLR tokens serve various functions; they can be delegated to FTSO data providers, for example, or staked to participate in governance. These two uses are not mutually exclusive and do not prevent the tokens from being used in other EVM-compatible dapps and smart contracts on Flare.  Wrapped FLR (WFLR) can be minted by depositing native FLR tokens into a smart contract and withdrawing the newly minted

Spark Token

Flare (FLR) is trending as the community speculates on its role within the XRP ecosystem, particularly following news regarding institutional treasury deployments and DeFi yield integration. Investors are actively discussing the potential for a major price move, with many focusing on staking rewards and long-term accumulation strategies while waiting for broader network utility to scale.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

Community members are actively promoting the token as a decentralized alternative to traditional retirement plans, often coordinating "DCA Fridays" to build their holdings. Supporters are rallying around the project's long-term movement narrative, frequently dismissing market volatility and panic selling as temporary hurdles on the path to reaching the goal of financial independence.

Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Leidos Holdings Inc

Leidos Holdings Inc. is trending as the community highlights the stock's role as a major defense systems integrator, particularly following significant contract wins for TSA airport security equipment and various U.S. government technology projects. Investors are actively debating the company's valuation compared to sector peers and its strategic position in long-term government software, cloud, and defense infrastructure spending.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as traders debate the feasibility of a rumored acquisition by GameStop, with the community polarized between those betting on the deal as a transformative growth catalyst and skeptics dismissing the massive valuation gap and financing hurdles. Investors are closely monitoring the stock's volatility as the market evaluates the potential for institutional accumulation and the broader implications for the company's e-commerce position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IBRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages IBRX Investors with Losses to Contact the Firm

IBRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages IBRX Investors with Losses to Contact the Firm IBRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages IBRX Investors...

ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. - IBRX

ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. - IBRX ImmunityBio...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX INVESTOR ALERT: Pomerantz Law Firm...

INVESTOR REMINDER: Berger Montague Notifies ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Class Action Lawsuit and Deadline

INVESTOR REMINDER: Berger Montague Notifies ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Class Action Lawsuit and Deadline INVESTOR REMINDER: Berger Montague Notifies ImmunityBio, Inc. (NASDAQ...

IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026

IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi...

IBRX Lawsuit Alleges Chairman Allegedly Overstated Drug Capabilities - ImmunityBio Investors Face Losses Following Chairman Allegedly Overstated Drug Capabilities: SueWallSt

IBRX Lawsuit Alleges Chairman Allegedly Overstated Drug Capabilities - ImmunityBio Investors Face Losses Following Chairman Allegedly Overstated Drug Capabilities: SueWallSt IBRX Lawsuit Alleges...

IBRX Lawsuit Alleges Company Allegedly Violated Drug Promotion Laws - ImmunityBio Investors Face Losses Following Company Allegedly Violated Drug Promotion Laws: Hagens Berman

IBRX Lawsuit Alleges Company Allegedly Violated Drug Promotion Laws - ImmunityBio Investors Face Losses Following Company Allegedly Violated Drug Promotion Laws: Hagens Berman IBRX Lawsuit Alleges...

IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit...

IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Promoted Unapproved Drug Uses: Levi & Korsinsky

IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Promoted Unapproved Drug Uses: Levi & Korsinsky IBRX...

<ul class="summary-bullets"><li>CEO Richard Adcock said the long-delayed Dunkirk manufacturing site is now “all systems go” after a unanimous resolution at a CCIDA board meeting.</li><li>The Dunkirk facility is expected to serve as a key U.S. production hub for Anktiva.</li><li>ImmunityBio has already invested over $100 million into the project.</li></ul>Shares of ImmunityBio, Inc. (IBRX) rose 1% in overnight trading on Wednesday after CEO Richard Adcock said that the company’s long-delayed Dunkirk manufacturing project is now “all systems go,” after local officials unanimously backed progress for the site supporting production of its cancer immunotherapy, Anktiva.&nbsp;<a href="https://stocktwits.com/symbol/IBRX">IBRX stock</a> slid nearly 5% to end at $6.96 on Tuesday. However, shares rose 1% in extended trading.&nbsp;<h2 class="st-heading-2">Anktiva US Production Site Back On Track</h2>Following a unanimous consent resolution at a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/live/o1PfKhGG0YY">meeting</a> of the Chautauqua County Industrial Development Agency (CCIDA) on Tuesday, ImmunityBio said its long-delayed Dunkirk facility is now moving forward as a key U.S. manufacturing hub for Anktiva production.CEO Richard Adcock said that progress had previously stalled after parts of the buildout were left incomplete when a contractor entered bankruptcy, delaying installation and certification required to activate the site.“Unfortunately, the original contractor didn’t finish parts and other parts didn’t get done. They got trapped in that bankruptcy, and so we all got kind of stuck in limbo land,” Adcock said. “Now that all that’s in our rear view mirror, we can just focus going forward… it’s really now all systems go.”Adcock said that ImmunityBio has already invested over $100 million into the project and expects to deploy “tens to hundreds of millions” more as the facility moves towards operational readiness. The company has already begun hiring for the restart, identifying at least 19 roles spanning engineering, scientific, and quality-control functions. “These are going to be people with master’s and PhD-level positions… everything is being built out now that we’ve effectively been able to get ourselves untrapped in this situation,” he said.A key milestone now in focus is the installation of $50 million in high-speed fill-finish equipment, followed by regulatory certification before engineering runs and initial manufacturing operations can begin.“It’s not just us getting it ready and running it. It’s then also bringing in the FDA, bringing in the state, bringing in everybody else that regulates it to make sure they’ll certify it,” Adcock said.<h2 class="st-heading-2">Dunkirk Lease Deal Clears Path For Anktiva</h2>Momentum at the Dunkirk site also follows a revised lease agreement with New York State that replaces the earlier $1 lease arrangement under the former Athenex project, which ended after the company went bankrupt in 2023.&nbsp;In February, ImmunityBio completed its acquisition of the leasehold interest in the ISO Class 5 pharma manufacturing facility in Dunkirk from Athenex, which includes upstream and downstream processing, fill-finish capability and large-scale lyophilization capacity to produce Anktiva in the U.S.&nbsp;Under the revised lease terms, the company will pay $525,000 in annual rent, commit at least $40 million toward facility improvements and hire at least 100 employees by the end of 2028, with the workforce expected to expand to 450 by 2032.&nbsp;<h2 class="st-heading-2">The Anktiva Bull Case</h2>The Dunkirk manufacturing push comes as Anktiva continues to drive ImmunityBio’s revenue growth and international expansion strategy. “Since we started this project, we were approved with Anktiva in zero countries. As we sit here today, it’s approved in 34 countries and territories,” Adcock said.Preliminary net product revenue for Anktiva hit $44.2 million in the first quarter, up 168% from a year earlier, while full-year 2025 net product revenue rose to $113 million, up 700% from 2024.&nbsp;Anktiva recently secured conditional authorization across 27 European Union member states, plus Iceland, Liechtenstein and Norway, and also recently became commercially available in Saudi Arabia. The company is also pushing additional programs evaluating Anktiva across lung, pancreatic, colorectal and brain cancers, alongside studies in severe pneumonia, sepsis, long COVID and acute respiratory distress syndrome.<h2 class="st-heading-2">How Do Retail Traders Feel About IBRX?</h2>On Stocktwits, retail sentiment for IBRX has slipped to ‘bearish’&nbsp; from ‘bullish’ levels a week ago amid a 242% surge in message volumes over the past month.<figure class="image"><img src="https://news.stocktwits-cdn.com/ibrx_ss_png_2acd0aa508.webp" alt="ibrx ss.png" width="969" height="139"><figcaption>TSLA sentiment and message volume as of April 29 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/BixbyKnolls/message/651636385">said</a>, “Major! Massive NEWS coming! Slingshot to new highs! Dunkirk and beyond!”<stembedurl>https://stocktwits.com/BixbyKnolls/message/651636385</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/BixbyKnolls/message/651631616">said</a>, “Ahead of plan on Dunkirk hiring! Unanimous approval to company plan and subsidies.&nbsp; BIg checks flowing out-&nbsp; Bigger money coming in soon.....”<stembedurl>https://stocktwits.com/BixbyKnolls/message/651631616</stembedurl>IBRX stock has jumped 165% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-lcid-sngx-srad-stocks-hit-52-week-lows-today/cZBq8xRRe33">LCID, SNGX, SRAD Stock Hit 52-Week Lows Today: What's Driving The Selloff?&nbsp;</a>

In this photo illustration, the ImmunityBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

IBRX Stock Climbs Overnight: ImmunityBio Declares ‘All Systems Go’ For Dunkirk Anktiva Manufacturing Push

The company ImmunityBio has already begun hiring to restart the Dunkirk facility, identifying at least 19 roles across multiple functions.

Equity

The company has already begun hiring to restart the Dunkirk facility, identifying at least 19 roles across multiple functions.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Continue higher

Sideways action

Retreat lower

What’s your read on the market for next week?

Stocktwits

Stocktwits Polls

Investors are bracing for key FDA milestones in May, specifically regarding sBLA classification and the upcoming earnings report.

With a high short interest and massive borrow ratios, bulls are closely tracking potential indicators of a short-covering event.

Discussion centers on the potential of NK-cell activation technology to redefine cancer care and replace outdated chemo treatments.

Massive investment in the Dunkirk facility and high-volume vial output suggest an anticipation of global commercial scale.

Current Price	$7.11
Prev Close	$7.10
Open	$7.05
Dividend Yield	0.00%
50-Day Moving Average	$8.13
Beta	1.86
Avg. Volume	13.93M
PE Ratio	-18.24

52-Week High	$12.43
52-Week Low	$1.83
Market Capitalization	$7.31B
EPS (Annual)	-$0.382
Price to Book	-14.37
Revenue Per Employee	$163,947.90

IBRX
ImmunityBio Inc

Feed

News

Sentiment

Fundamentals

Info

Latest IBRX News

IBRXImmunityBio Inc